Уремический токсин паракрезол у больных с терминальной стадией ХДН

Автор: Сивков Нии Урологии Минздравсоцразвития Рф, Синюхин Нии Урологии Минздравсоцразвития Рф, Бебешко Нии Урологии Минздравсоцразвития Рф

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Хроническая почечная недостаточность

Статья в выпуске: 1, 2012 года.

Бесплатный доступ

Хроническая почечная недостаточность, уремические токсины, р-крезол, жидкостная хроматография, p-сresol

Короткий адрес: https://sciup.org/142188294

IDR: 142188294

Список литературы Уремический токсин паракрезол у больных с терминальной стадией ХДН

Coresh J., Byrd-Holt D., Astor B.C., Briggs J.P., Eggers P.W., Lacher D.A., Hostetter T.H. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000//J Am Soc Nephrol. 2005. Vol. 16. P. 180188.
USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: U.S. Renal Data System, 2006.
Depner T.A. Uremic toxicity: urea and beyond.//Semin Dial. 2001.Vol. 14. P. 246-251.
Valderrabano F., Jofre R., Lopez-Gomez J.M. Quality of life in end-stage renal disease patients//Am J Kidney Dis. 2001.Vol. 38. P. 443-464.
Vanholder R., De Smet R., Glorieux G., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., Descamps-Latscha B., Henle T., Jörres A., Lemke H.D., Massy Z.A., Passlick-Deetjen J., Rodriguez M., Stegmayr B., Stenvinkel P., Tetta C., Wanner C., Zidek W. Review on uremic toxins: classification, concentration, and interindividual variability//Kidney Int. 2003. Vol. 63. P. 1934-1943.
Eknoyan G., Beck G.J., Cheung A.K., Daugirdas J.T., Greene T., Kusek J.W., Allon M., Bailey J., Delmez J.A., Depner T.A., Dwyer J.T., Levey A.S., Levin N.W., Milford E., Ornt D.B., Rocco M.V., Schulman G., Schwab S.J., Teehan B.P., Toto R., Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis//N Engl J Med. 2002.Vol. 347, № 25. P. 2010-2019.
Canaud B., Morena M., Leray-Moragues H., Chalabi L., Cristol J.P. Overview of clinical studies in hemodiafiltration: what do we need now?//Hemodial Int. 2006.Vol. 10, Suppl 1. P.5-12.
Hanly P.J., Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis//N Engl J Med. 2001. Vol. 344. P. 102-107.
Vanholder R., Schepers E., Pletinck A., Neirynck N., Glorieux G. An update on protein-bound uremic retention solutes//J Ren Nutr. 2012. Vol. 22, № 1. P. 90-94.
Dou L., Cerini C., Brunet P., Guilianelli C., Moal V., Grau G., De Smet R., Vanholder R., Sampol J., Berland Y. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines.//Kidney Int. 2002. Vol. 62, № 6. P. 1999-2009.
Niwa T. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection//Clin Chem. 1993. Vol.39, № 1. P. 108
De Smet R., David F., Sandra P., Van Kaer J., Lesaffer G., Dhondt A., Lameire N., Vanholder R. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure//Clin. him. Acta. 1998.Vol. 278. P. 1-21.
Wengle B., Hellström K. Volatile phenols in serum of uraemic patients//Clin Sci.1972. Vol. 43. P. 493-498.
De Loor H., Bammens B., Evenepoel P., De Preter V., Verbeke K. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum//Clin. Chem. 2005. Vol. 51, № 8. P. 1535-1538.
De Smet R., Van Kaer J., Van Vlem B., De Cubber A., Brunet P., Lameire N., Vanholder R. Toxicity of free p-cresol: a prospective and cross-sectional analysis//Clin. Chem. 2003. Vol. 49, № 3. P. 470-478.
Cheng-Jui Lin, Chih-Kuang Chuang, Hsuan-Liang Liu, Tuen-Jen Wang Han-Hsiang Chen, Fang-Ju Sun and Chih-Jen Wu The serum levels of P-cresol and Indoxyl sulfate in different hemodialysis vintage//J Clin Medicine and Research.2011. Vol. 3, № 8. P. 114-119.
Vanholder R., De Smet R., Waterloos M.A., Van Landschoot N., Vogeleere P., Hoste E., Ringoir S.Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol.//Kidney Int. 1995. Vol. 47. P. 510-517.
de Carvalho J.T. Jr., Dalboni M.A., Watanabe R., Peres A.T., Goes M.A., Manfredi S.R., Canziani M.E., Cendoroglo G.S., Guimaräes-Souza N., Batista M.C., Cendoroglo M. Effects of spermidine and p-cresol on polymorphonuclear cell apoptosis and function//Artif Organs. 2011. Vol. 35, № 2. P. 27-32.
Laetitia Dou, Claire Cerini, Philippe Brunet, Catherine Guilianelli, Valérie Moal, Georges Grau, Rita De Smet, Raymond Vanholder, José Sampol and Yvon Berland. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines//Kidney International 2002. Vol. 62, P. 1999-2009.

Еще

Статья